Skip to content

Study · Not a test of the peptide alone · 1996

2 results

Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA.

Johnson MC, McCormack RJ, Delgado M, Martinez C, Ganea D

Journal of neuroimmunology1 Aug 1996Cited by 37 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Vasoactive intestinal peptide (VIP, aviptadil) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Vasoactive intestinal peptide (VIP, aviptadil).

  1. 01LabNot a test of Vasoactive intestinal peptide (VIP, aviptadil) aloneIn vitro (cells)Mechanism

    In murine spleen cells, thymocytes, and CD4+ and CD8+ T cells, VIP-R1 mRNA was expressed in stimulated and unstimulated cells.

    In plain wordsIn mouse immune cells, the gene message for the VIP receptor type 1 was found in several cell types.

    Outcome
    Not applicableVIP-R1 mRNA expression in murine lymphocyte subpopulations
    Study

    mousen: not reported in source

    murine lymphocyte subpopulations
    Outcome group
    Receptor activity and mechanism · Immune and inflammation

    Source sentences

    Summary
    By using RT-PCR. RNase protection assay, cDNA cloning, and sequence analysis, we show that stimulated and unstimulated murine spleen cells, thymocytes. CD4+ and CD8+ T-cells express VIP-R1.
    1 context sentence
    Summary · context
    Here we report on the expression of VIP-R1 mRNA in various murine lymphocyte subpopulations.

    In this study, Vasoactive intestinal peptide (VIP, aviptadil) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Vasoactive intestinal peptide (VIP, aviptadil).

  2. 02LabNot a test of Vasoactive intestinal peptide (VIP, aviptadil) aloneIn vitro (cells)Mechanism

    The VIP-R1 fragment amplified from murine brain, thymocytes, spleen cells and CD4+ T cells had identical nucleotide sequences and high homology with rat and human VIP-R1.

    In plain wordsIn mice, the VIP receptor type 1 gene piece was identical in brain and immune cells and very like the rat and human version.

    Outcome
    Not applicableSequence of VIP-R1 fragment across tissues
    Study

    mousen: not reported in source

    murine lymphocyte subpopulations
    Outcome group
    Receptor activity and mechanism · Immune and inflammation

    Source sentences

    Summary
    The VIP-R1 fragment amplified from murine brain, thymocytes, spleen cells and CD4+ T-cells share identical nucleotide sequences, and a high degree of homology with the corresponding nonlymphoid rat and human VIP-R1 sequences.
    1 context sentence
    Summary · context
    Here we report on the expression of VIP-R1 mRNA in various murine lymphocyte subpopulations.

    In this study, Vasoactive intestinal peptide (VIP, aviptadil) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Vasoactive intestinal peptide (VIP, aviptadil).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.